Physician profile
Megahn Pasquali
NPI 1609587682
$540.71
in general payments reported to CMS, 2019-2025
11 companies · $541 in 2025
The $541 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $139.29 | 2025 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $92.78 | 2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $76.72 | 2025 | Korlym |
| Lilly USA, LLC | $68.86 | 2025 | Mounjaro |
| Sanofi-Aventis U.S. LLC | $39.74 | 2025 | |
| Edwards Lifesciences Corporation | $33.44 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $19.81 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.62 | 2025 | Lifevest |
| Amgen INC. | $18.05 | 2025 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.55 | 2025 | Xifaxan |
| Baxter Healthcare | $15.85 | 2025 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megahn Pasquali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.